PATENT CLAIM ANALYSIS

Application Number: 16195264
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-10
Patent Classification: ["514", "283000"]

Abstract:
The present invention provides SN-38 compositions for treating cancer.

Claim (Index 4):
The composition according to  claim 2 , further comprising at least one of 7-ethyl camptothecin, 10-hydroxy camptothecin, and 10-hydroxy-7-methyl camptothecin.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15892216', '14204698', '14669611', '14674117', '14656200']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6525511665380762
- 35 USC 102 Novelty (BERT): 0.5570664263189513
- Combined Prediction Score: 0.6430026925161638
- Mean Citation Score: 215.021208
- Max Citation Score: 399.29816
- Similarity Product: 395.4054755132962

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test